1Cohen M, Demers CS, Gurfinkel EP, et al. A comperison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaprain in Non-Q-Wave Coronary Events Study Group[J]. N Engl J M
2Green D, Hirsh J, Heir J, et al. Low molecular weight heparin: A critical analysis of clinical trials[J]. Pharmacol Rev,1994,46(1):89-109.
3Gurfinkel EP,Manos EJ, Mejail RI, et al.Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia[J]. J Am coll cardiol,1995,26(2):313-318.
